← FDA Drug Approvals (Drugs@FDA)

XOLAIR

BLA · Biologics License Application · Sponsor: GENENTECH · Approved 2003-06-20

Drug application

FDA Application #

BLA103976

Application type

Biologics License Application

Brand name

XOLAIR

Generic name

OMALIZUMAB

Active ingredients

OMALIZUMAB

Dosage form

VIAL

Route

—

Marketing status

Prescription

Sponsor

GENENTECH

Manufacturer

Genentech, Inc.

First approval

2003-06-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown